Omics · study · 2026
scRNAseq of Kaede red+ CD45+ cells from draining-lymph nodes of YUMMER1.7 tumors day 21 post implantation
Listed in NCBI GEO
Successful neoadjuvant immune checkpoint blockade (ICB) therapy depends on the maintenance of a pool of stem-like CD8+ T cells that are enriched in tumor-draining lymph nodes (LN).
Description
Upon ICB, stem-like CD8+ T cells activate and proliferate to generate effector T cells that seed the intratumoral response. Yet, how the stem-like niche is maintained over time in cancer remains poorly understood.
Here, we identify a continuous lymphatic circuit that sustains the stem-like CD8+ T cell pool. Using photoconvertible fate-mapping, we demonstrate that effector CD8+ T cells egress from the tumor microenvironment via tumor-associated lymphatic vessels, and migrate back to the draining LN. These tumor-specific, migratory effector T cells avoid chronic antigen stimulation in the tumor, re-express the transcription factor associated with self-renewal, TCF1, and subsequently enter a stem-like state in the LN.
Read the rest (2 more)
We find that chronic antigen presentation in LNs by dendritic cells drives the local proliferation and transient residence of tumor-egressing T cells thereby inflating the LN stem-like population. Consequently, maintenance of stem-like T cells and ICB response depends on constitutive lymphatic transport, which sustains both effector egress and antigen presentation in the LN. Finally, we find that metastasis disrupts the stem-like LN niche in patients and impairs response to ICB in mice.
We, therefore, define a continuous, peripheral lymphatic circuit that recycles tumor-experienced effector T cells to fuel durable systemic anti-tumor immune responses, providing mechanistic insight into the enhanced efficacy of neoadjuvant immunotherapy and highlighting the importance of preserving lymphatic transport for optimal cancer immunotherapy outcomes.
Links
Get the data
- GEO FTP directory ftp.ncbi.nlm.nih.gov/geo/series/GSE322nnn/GSE322572 ↗
download · from NCBI GEO
Where it is published
- GEO accession page ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE322572 ↗
landing page · from NCBI GEO
Documentation and papers
- PRJNA1430563 ncbi.nlm.nih.gov/bioproject/PRJNA1430563 ↗
project · from NCBI GEO
- PubMed 42146677 pubmed.ncbi.nlm.nih.gov/42146677 ↗
publication · from NCBI GEO
Topics
- Stated by source
- Expression profiling by high throughput sequencing · Mus musculus
- From keywords
- Life Sciences
- Inferred from text
- Cancer 75%
Provenance · 1 source records, 8 field assertions
| Source | Key | Last seen | Raw |
|---|---|---|---|
| NCBI GEO | GSE322572 | 14 d ago | JSON v1 |
| Field | Assertion | Extractor | Evidence |
|---|---|---|---|
| access_level | source · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| concepts[disease].local:disease:cancer | enrichment · NCBI GEO | keyword-concept-rules@1.0.0 | title+description (75%) |
| concepts[field].local:field:life-sciences | mapping · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencing | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /gdstype |
| concepts[organism].NCBITaxon:10090 | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /taxon |
| description | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /summary |
| publication_date | source · NCBI GEO | connector:ncbi_geo@1.0.0 | |
| title | source · NCBI GEO | connector:ncbi_geo@1.0.0 | /title |